Who
Lauren Chung
Director
Company insider
Files Form 4 as: Director, Profusa; Director, Aditxt; Director, Cure Pharmaceutical Holding.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 6 Aug 2020
- Last trade
- 26 Jan 2026
- Last filed
- 30 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jan 2026filed 30 Jan 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —30,000 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —30,000 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
| 29 Sep 2021filed 1 Oct 2021 | Aditxtoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,500 at $0.00 | filing |
| 14 Jul 2021filed 1 Oct 2021 | Aditxtoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 23 Sep 2020filed 27 May 2021 | Cure Pharmaceutical Holdingoption or derivative | SEC FORM 4 Code A | —61,654 at $0.00 | filing |
| 6 Aug 2020filed 27 May 2021 | Cure Pharmaceutical Holding | SEC FORM 4 Code A | —21,579 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.